Broadview Ventures, a venture capital firm, and Hatteras Venture Partners, an investment company, led a $15m Series A round in Cardiosens, a digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint Health Ventures, and Portal Innovations. "We're excited to have our new investors join our mission of combating preventable cardiovascular disease. Recent data has underscored both the need and potential impact of actionable patient monitoring solutions and this capital allows us to accelerate the clinical development of our platform," Amit Gupta, Cardiosense Co-founder and CEO.